The iCMLf is hosting conversations on CML and COVID-19 with renowed experts in CML that address key questions on how to manage patients with CML during the COVID-19 pandemic. You can view recordings of the conversations here. The content of the presentations express the individual opinions of the respective experts.
Professor Jorge Cortes Director, Georgia Cancer Center Augusta (USA)
|
|
CML in the era of COVID-19 incl. Q&A session
Watch the webinar to hear Professor Cortes' experience and perspectives on topics like;
- COVID-19 in cancer patients in China / New York
- Outcomes in patients with cancer and COVID-19
- COVID-19 mortality in patients with cancer
- COVID-19 in patients with hematological malignancies
- COVID-19 in patients with chronic myeloid leukemia
- Treating leukemia in the time of COVID-19
- TKI's and COVID-19
- Vaccination in patients with CML
- CML and COVID-19 recommendations
|
Professor Gianantonio Rosti St Orsola University Hospital Bologna (Italy)
|
|
Management recommendations for patients with CML during the pandemic incl. Q&A Session
Watch the webinar to hear Professor Rosti's experience and perspectives on topics like;
- Newly diagnosed patients
- How to begin therapy?
- What therapies and why?
- Any concerns about delaying therapy?
- Recommendations for patients
- Patients on TKI therapy
- Should therapy be switched or stopped pre-emptively?
- How should patients with CML be monitored?
- Treatment-free-remission, suggestions
- For those patients considering TFR
- For those patients already in TFR
|
Dr Delphine Réa Hôpital Saint-Louis Paris (France)
|
|
Management of patients with CML and COVID-19 incl. Q&A Session
Watch the webinar to hear Dr Rea's experience and perspectives on topics like;
- SARS-CoV-2 infection and COVID-19: symptoms and diagnostic tools
- Classication of COVID-19 according to WHO
- CML and COVID-19: personal experience
- CML and asymptomatic SARS CoV-2 infection
- CML and mild/moderate/severe/critical (WHO) COVID-19
- Adapting TKI treatment strategy according to COVID-19 severity: personal suggestions
- Drugs used or tested against COVID-19: potential interactions with CML TKI's
- Prevention of COVID-19 in CML patients
|
Professor Hemant Malhotra Mahatma Gandhi Medical College Hospital, Jaipur (India)
Dr Katia Pagnano University of Campinas, Sao Paulo (Brazil)
|
|
What do we know about COVID-19 and CML so far from real-world? Perspectives from India and Brazil incl. Q&A Session
Watch the webinar to hear Prof. Malhotra's and Dr Pagnano's experience and local perspectives on topics like;
- Global data on CML and COVID-19 from the iCMLf/ASH
- CML and COVID-19 cases in India and Brazil
- CML and COVID-19: local experiences, strategy and specific challenges
- Changes in management of patients with CML during the pandemic
- Prevention of Coronavirus infection at local centres in India/Brazil
|